FAST NEWS: Lepu Biopharma to raise $32 million in share sale
The Latest: Innovative drug maker Lepu Biopharma Co. Ltd. (2157.HK) announced on Friday it will place up to 51.17 million shares, or about 2.99% of its overall issued share capital, for…
Lepu Biopharma gets taste of spring with first revenues
The ADC-focused drug company logged its first-ever sales late last year, kicking of the next phase of its development Key Takeaways: Lepu Biopharma began to sell its first product last…
Recent Articles
RELATED ARTICLES
-
WuXi Biologics hatches new baby with ADC drug unit IPO
2269.HK -
Akeso marks profit milestone with swift rights issue
9926.HK
-
HBM gets health boost from drug licensing deals
2142.HK
- Funding boost gets Sunho Biologics over the IPO filing line
-
RemeGen hopes for pain relief from expanded drug uses
9995.HK 688331.SHG
-
AstraZeneca pays hefty price for Chinese weight-loss drug
AZN.US
